Asthma, Nasal Disease, and Allergy Research Center of New England

Providence, Rhode Island 02906

0 studies enrolling now · 3 studies all time

What they study most

Allergic Rhinitis, Asthma, Perennial Allergic Rhinitis

Studies at this site

• A 6 Month Safety and Efficacy Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) in the Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older — Completed
• A 6 Month Study of Once Daily Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol in The Treatment of Perennial Allergic Rhinitis (PAR) in Subjects 12 Years and Older — Completed
• A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL — Completed